ACCUPRIL Drug Patent Profile
✉ Email this page to a colleague
When do Accupril patents expire, and when can generic versions of Accupril launch?
Accupril is a drug marketed by Pfizer Pharms and is included in one NDA.
The generic ingredient in ACCUPRIL is quinapril hydrochloride. There are eleven drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the quinapril hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Accupril
A generic version of ACCUPRIL was approved as quinapril hydrochloride by LUPIN on June 20th, 2006.
Summary for ACCUPRIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 85 |
Clinical Trials: | 6 |
Patent Applications: | 3,370 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ACCUPRIL |
What excipients (inactive ingredients) are in ACCUPRIL? | ACCUPRIL excipients list |
DailyMed Link: | ACCUPRIL at DailyMed |
Recent Clinical Trials for ACCUPRIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of Nebraska | Phase 4 |
Nova Scotia Health Authority | Phase 4 |
Nova Scotia Health Research Foundation | Phase 4 |
Pharmacology for ACCUPRIL
Drug Class | Angiotensin Converting Enzyme Inhibitor |
Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Anatomical Therapeutic Chemical (ATC) Classes for ACCUPRIL
US Patents and Regulatory Information for ACCUPRIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer Pharms | ACCUPRIL | quinapril hydrochloride | TABLET;ORAL | 019885-001 | Nov 19, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer Pharms | ACCUPRIL | quinapril hydrochloride | TABLET;ORAL | 019885-004 | Nov 19, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer Pharms | ACCUPRIL | quinapril hydrochloride | TABLET;ORAL | 019885-002 | Nov 19, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer Pharms | ACCUPRIL | quinapril hydrochloride | TABLET;ORAL | 019885-003 | Nov 19, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ACCUPRIL
International Patents for ACCUPRIL
See the table below for patents covering ACCUPRIL around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Netherlands | 930077 | ⤷ Try a Trial | |
European Patent Office | 0049605 | SUBSTITUTED ACYL DERIVATIVES OF 1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACIDS, SALTS THEREOF, PHARMACEUTICAL COMPOSITIONS CONTAINING THE DERIVATIVES OR SALTS, AND THE PRODUCTION OF THE SAME | ⤷ Try a Trial |
Germany | 3176010 | ⤷ Try a Trial | |
U.S.S.R. | 1148560 | METHOD OF OBTAINING SUBSTITUTED ACUL DERIVATIVE OF 1,2,3,4-TETRAHYDROISOQUINOLINE--3-CARBOXYLIC ACID OR PHARMACEUTICALLY ACCEPTED SALTS | ⤷ Try a Trial |
Hong Kong | 1006003 | ⤷ Try a Trial | |
Israel | 63806 | SUBSTITUTED ACYL DERIVATIVES OF 1,2,3,4-TETRAHYDROISOQUINOLINE-3-CARBOXYLIC ACIDS,THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | ⤷ Try a Trial |
Ireland | 880142 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ACCUPRIL
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0096157 | SPC/GB95/011 | United Kingdom | ⤷ Try a Trial | SPC/GB95/011:, EXPIRES: 20060930 |
0049605 | SPC/GB93/099 | United Kingdom | ⤷ Try a Trial | SPC/GB93/099, EXPIRES: 20040413 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |